Balanced news tone
News Sentiment
SGHT sentiment intelligence
Sight Sciences Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
49
Balanced news tone
56 relevant articles
News tone and price action are not far from neutral.
79/100 classification confidence.
directly relevant articles
high-authority source matches
-2.4% over one week, +3.7% over four weeks, trend inactive, and near fair-value range.
Have Insiders Sold Sight Sciences Shares Recently?
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
79/100 classification
One-week reaction
-2.4%
Price reacting lower
Trend fit
Trend inactive
3.7% over four weeks
Fair value
10.9%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
4
Neutral
44
Negative
8
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Market source
Industry context
Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 18:07
- Source
- Market source
Simply Wall Street
Direct company coverage
Have Insiders Sold Sight Sciences Shares Recently?
Sight Sciences Co-Founder Paul Badawi recently sold US$155k worth of shares at US$5.42, which was 0.5% of his holding. While this sale, and a previous larger one at a higher price, indicates more insider selling than buying over the last year, the stock was sold above the current
- Tone
- Negative 40/100
- Event
- Market update
- Published
- 09 Jul 2026 10:49
- Source
- Simply Wall Street
Moomoo
Direct company coverage
Citi Maintains Sight Sciences(SGHT.US) With Hold Rating, Raises Target Price to $6
Citi has reiterated its Hold rating for Sight Sciences (SGHT.US), increasing the target price for the company's stock to $6. This updated target indicates Citi's revised valuation for the medical device company.
- Tone
- Positive 70/100
- Event
- Analyst action
- Published
- 08 Jul 2026 21:12
- Source
- Moomoo
AD HOC NEWS
Direct company coverage
Sight Sciences Inc focuses on glaucoma devices as investors watch Nasdaq trading
Sight Sciences Inc is a US-based medical technology company specializing in devices for glaucoma and dry eye treatment, with its shares listed on Nasdaq. The company’s strategy focuses on developing minimally invasive solutions to address chronic eye conditions in a growing ophth
- Tone
- Positive 67/100
- Event
- Market update
- Published
- 08 Jul 2026 18:40
- Source
- AD HOC NEWS
Investing.com UK
Direct company coverage
Form 4 Sight Sciences Inc For: 6 July By Investing.com
This article from Investing.com announces the filing of Form 4 for Sight Sciences Inc. on July 6. It also includes general market data, news headlines, and various financial statistics as supplementary content. The core purpose of the article is to report on the Form 4 filing.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 23:11
- Source
- Investing.com UK
Stock Titan
Direct company coverage
Sight Sciences (NASDAQ: SGHT) CFO sells 6,902 shares to cover RSU tax bill
Sight Sciences CFO James Rodberg sold 6,902 shares of common stock on July 2, 2026, at a weighted average price of $5.36 per share. The sale was conducted to cover tax obligations related to the vesting of his restricted stock units (RSUs). Following this transaction, Rodberg ret
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 20:49
- Source
- Stock Titan
Investing.com
Direct company coverage
Sight Sciences CLO Jeremy Hayden sells $70,133 in stock
Jeremy Hayden, CLO at Sight Sciences (NASDAQ:SGHT), sold 12,733 shares for $70,133 to cover tax liabilities associated with restricted stock units. Despite this insider sale, Hayden still directly holds 357,037 shares. Investing.com analysis suggests the stock is currently overva
- Tone
- Negative 36/100
- Event
- Market update
- Published
- 07 Jul 2026 20:49
- Source
- Investing.com
Investing.com Nigeria
Direct company coverage
Form 144 Sight Sciences For: 6 July By Investing.com
This article from Investing.com briefly notes the filing of Form 144 for Sight Sciences (SGHT) on July 6. The content is primarily a placeholder for this financial reporting and includes various market data, news headlines, and related financial information, but no further detail
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 20:40
- Source
- Investing.com Nigeria
TradingView
Direct company coverage
Price to earnings forward of Sight Sciences, Inc. – NASDAQ:SGHT
This article provides financial information for Sight Sciences, Inc. (NASDAQ: SGHT), specifically focusing on its price-to-earnings forward ratio. The content appears to be a stub or an incomplete data point from a financial platform like TradingView, as it lacks detailed analyti
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Jul 2026 10:12
- Source
- TradingView
Investing.com
Direct company coverage
Sight Sciences CFO James Rodberg sells $36,994 in common shares
Sight Sciences CFO James Rodberg sold 6,902 common shares worth $36,994 to cover tax liabilities from vesting stock units. Following the transaction, Rodberg directly holds 224,037 shares. The company recently reported mixed Q1 2026 earnings, exceeding revenue expectations but mi
- Tone
- Negative 38/100
- Event
- Earnings
- Published
- 07 Jul 2026 09:40
- Source
- Investing.com
Stock Titan
Direct company coverage
Sight Sciences (SGHT) EVP sells shares to cover RSU-related tax obligations
Taylor Brenton, EVP of Operations & R&D at Sight Sciences (SGHT), sold 2,829 shares of company stock at a weighted average price of $5.42 per share. This sale, totaling $15,333, was primarily to cover tax obligations arising from the vesting of restricted stock units (RSUs) rathe
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 08:11
- Source
- Stock Titan
Investing.com Nigeria
Direct company coverage
Sight Sciences CFO James Rodberg sells $36,994 in common shares By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 00:04
- Source
- Investing.com Nigeria
Investing.com South Africa
Direct company coverage
Sight Sciences COO Alison Bauerlein sells $129,626 in stock By Investing.com
Sight Sciences COO Alison Bauerlein sold 24,184 shares of company stock worth $129,626 to cover tax liabilities. Following the sale, she directly holds 664,709 shares. This transaction comes amidst mixed Q1 2026 earnings for Sight Sciences, where revenue beat expectations but EPS
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Jul 2026 00:11
- Source
- Investing.com South Africa
Investing.com South Africa
Direct company coverage
Sight Sciences CLO Jeremy Hayden sells $70,133 in stock By Investing.com
Jeremy B. Hayden, Chief Legal Officer at Sight Sciences, Inc. (NASDAQ:SGHT), sold 12,733 shares of company stock for $70,133 to cover tax liabilities. Following the sale, he still directly holds 357,037 shares, including unvested restricted stock units. This transaction comes aft
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 00:11
- Source
- Investing.com South Africa
Stock Titan
Direct company coverage
Sight Sciences (SGHT) COO sells shares to cover RSU tax, retains 664,709 stake
Sight Sciences, Inc. COO Alison Bauerlein sold 24,184 shares of common stock at a weighted average price of $5.36 per share. This sale was conducted to cover tax liabilities stemming from the vesting of restricted stock units (RSUs). Following this transaction, Bauerlein still ho
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 06 Jul 2026 23:11
- Source
- Stock Titan
Investing.com South Africa
Direct company coverage
Sight Sciences CEO Paul Badawi disposes of $155,467 in stock By Investing.com
Paul Badawi, President and CEO of Sight Sciences Inc. (NASDAQ:SGHT), sold 28,684 shares of the company's common stock for $155,467 on July 1, 2026, to cover tax liabilities related to restricted stock units. Following this transaction, Badawi directly holds over 6.1 million share
- Tone
- Negative 39/100
- Event
- Market update
- Published
- 06 Jul 2026 23:11
- Source
- Investing.com South Africa
Stock Titan
Direct company coverage
Sight Sciences (NASDAQ: SGHT) CLO sells 12,733 shares to cover RSU taxes
Sight Sciences Chief Legal Officer Jeremy B. Hayden sold 12,733 shares of common stock at a weighted average price of $5.51 per share. This sale was explicitly made to cover tax liabilities arising from the vesting of restricted stock units (RSUs), rather than a discretionary red
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 23:11
- Source
- Stock Titan
Stock Titan
Direct company coverage
Sight Sciences (SGHT) CTO sells 7,418 shares to cover RSU tax liability
Sight Sciences, Inc. Chief Technology Officer David Badawi sold 7,418 shares of common stock at a weighted average price of $5.508 per share to cover tax liabilities from restricted stock unit vesting. Following this transaction, Badawi still holds 1,982,872 shares, comprising co
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 23:11
- Source
- Stock Titan
Stock Titan
Direct company coverage
Sight Sciences (SGHT) CEO’s 28,684-share tax sale and updated holdings
Sight Sciences, Inc. President and CEO Paul Badawi sold 28,684 shares of common stock at a weighted average price of $5.42 per share. This sale was conducted to cover his tax liability arising from the vesting of restricted stock units (RSUs). After this transaction, Badawi still
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 23:11
- Source
- Stock Titan
Stock Titan
Direct company coverage
[144] Sight Sciences, Inc. SEC Filing
This article details a Form 144 SEC filing by Sight Sciences, Inc. (SGHT) concerning a proposed sale of securities. The filing indicates the sale of 7,418 common shares acquired via restricted stock vesting on June 30, 2026, with an approximate sale date of July 6, 2026, through
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 21:12
- Source
- Stock Titan
Investing.com
Direct company coverage
Sight Sciences COO Alison Bauerlein sells $129,626 in stock
Alison Bauerlein, COO of Sight Sciences, Inc. (NASDAQ:SGHT), sold 24,184 shares of company stock for approximately $129,626 to cover tax liabilities from vested restricted stock units. Following the sale, she directly holds 664,709 shares, including unvested RSUs. The company rec
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 09:40
- Source
- Investing.com
Investing.com
Direct company coverage
Sight Sciences EVP Brenton Taylor sells $15,333 in company stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- Investing.com
Stock Titan
Direct company coverage
SGHT (NASDAQ: SGHT) affiliate files Form 144 to sell 12,733 shares
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- Stock Titan
Investing.com
Direct company coverage
Sight Sciences CTO David Badawi sells $40,858 in stock
Sight Sciences CTO David Badawi sold 7,418 shares of the company's common stock for $40,858 to cover tax liabilities from restricted stock units. Following the sale, Badawi still holds a significant number of shares, including vested and unvested RSUs. InvestingPro analysis sugge
- Tone
- Negative 39/100
- Event
- Market update
- Published
- 06 Jul 2026 07:39
- Source
- Investing.com
TradingView
Direct company coverage
Price to book forward of Sight Sciences, Inc. – NASDAQ:SGHT
This article displays the "Price to book forward" financial metric for Sight Sciences, Inc. (NASDAQ: SGHT). It presents the current value, change, and percentage change for this specific financial statistic. The content is presented by TradingView, sourcing data from ICE Data Ser
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jul 2026 13:40
- Source
- TradingView
Investing.com Canada
Direct company coverage
Form 144 Sight Sciences For: 2 July By Investing.com
This article announces the filing of Form 144 for Sight Sciences (SGHT) on July 2. Form 144 filings indicate an insider's intent to sell restricted stock. The brief piece reiterates the headline multiple times and includes a market data table.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 22:39
- Source
- Investing.com Canada
Stock Titan
Direct company coverage
SGHT (NASDAQ) Form 144 shows 6,902-share resale after restricted-vesting
Sight Sciences, Inc. (SGHT) filed a Form 144 notification indicating a proposed sale of 6,902 shares of common stock stemming from restricted stock vesting. The filing also disclosed 54,409,942 shares outstanding as of July 2, 2026, and reported a prior sale of 7,231 shares on Ap
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 21:39
- Source
- Stock Titan
Stock Titan
Direct company coverage
SGHT (NASDAQ) insider resale notice: 24,184 shares tied to vesting
Sight Sciences, Inc. (SGHT) filed a Form 144 notice disclosing the proposed resale of 24,184 shares of common stock associated with a restricted stock vesting event on June 30, 2026. The filing also detailed two prior open-market sales by an insider on April 2, 2026, and May 18,
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 21:39
- Source
- Stock Titan
Stock Titan
Direct company coverage
2,829 Restricted Shares for SGHT (NASDAQ: SGHT) - Form 144 Notice
A Form 144 notice has been filed for Sight Sciences, Inc. (NASDAQ: SGHT), indicating an intent to sell 2,829 shares of common stock stemming from restricted stock vesting. The event date for the vesting is June 30, 2026, with Fidelity Brokerage Services LLC listed as the broker.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 21:09
- Source
- Stock Titan
Stock Titan
Direct company coverage
SGHT (NASDAQ: SGHT) files notice for 28,684‑share restricted stock sale
Sight Sciences, Inc. (NASDAQ: SGHT) has filed a Form 144 notice for the proposed sale of 28,684 shares of common stock resulting from restricted stock vesting on June 30, 2026. The filing also disclosed a previous sale by Paul Badawi of 29,244 shares on April 1, 2026, for $108,08
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 21:09
- Source
- Stock Titan